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ABStRACt
Expression of anti‑apoptotic genes is frequently elevated in tumors, where they increase 
resistance to chemotherapeutic agents and predict poor patient outcomes. However, key 
cellular factors regulating anti‑apoptotic genes in tumors remain unknown. Increased 
expression of the regenerating (Reg) genes is commonly observed in gastrointestinal 
(GI) malignancies including colorectal cancer (CRC). We therefore examined Reg gene 
expression and associated changes in anti‑apoptotic genes in an animal model of GI 
tumorigenesis. Using real time RT‑PCR, we measured expression of Reg genes in human 
colorectal adenocarcinoma specimens, colon adenocarcinoma cell lines and adenomas 
from multiple intestinal neoplasia (min) mice heterozygous for a germ‑line mutation of 
the adenomatous polyposis coli (APC) gene. Expression of Reg genes is increased in 
human colorectal adenocarcinomas and in the intestine of APCmin/+ mice at four weeks 
of age, a time preceding the spontaneous second mutation in the APC gene. Individual 
Reg genes exhibited regional expression profiles across the GI tract in mice. Adenomas 
from 14‑week old mice had significant increases in at least one member of the Reg gene 
family, most commonly Reg IV and an associated increase in expression of the anti‑apop‑
totic gene, Bcl‑2. Addition of exogenous recombinant human Reg IV to human colon 
adenocarcinoma cells significantly increased Bcl‑2 and Bcl‑xL expression and induced 
resistance to ionizing radiation. These results show that dysregulation of Reg genes occur 
early in tumorigenesis. Furthermore, increased expression of Reg genes, specifically 
Reg IV contribute to adenoma formation and lead to increased resistance to apoptotic 
cell death in CRC.
IntRODuCtIOn
Tumorigenesis is a multistep process involving somatic mutations or epigenetic 
changes affecting tumor suppressor and oncogenes.1,2 Additional genetic alterations create 
a permissive environment for clonal expansion of cells that are resistant to apoptosis. 
Advanced forms of common malignancies, such as colorectal, gastric, prostate or breast 
carcinoma are often associated with poor responses to adjuvant chemotherapy (CT) and/
or ionizing radiation (IR).3 Apoptosis is a prominent mechanism for cell death following 
CT or IR.4 Accordingly, considerable attention has been given to the Bcl-2 family genes 
as possible regulators of intrinsic tumor resistance to therapy.5 Repressors of programmed 
cell death, such as Bcl-2 and Bcl-xL, decrease IR- and CT-induced apoptotic cell death in 
cell culture.6 However, key cellular factors that regulate expression of anti-apoptotic genes 
in tumors remain unknown. Defining dominant pathways responsible for modulation of 
apoptosis-regulating proteins would significantly enhance our understanding of tumor 
behavior and could broaden current strategies for therapeutic intervention.
The regenerating (Reg) genes constitute a family belonging to calcium dependent 
(C-type) lectin gene superfamily.7-10 The Reg family genes included six members (Reg I, 
Reg II, Reg IIIa, Reg IIIb, Reg IIId and Reg IIIg) in the mouse and three members (Reg 
Ia, Reg Ib and Reg III) in humans.11 Human Reg IV, a novel member of the family was 
identified by high throughput sequencing of a library derived from patients with ulcerative 
colitis, constituting fourth member of the Reg gene family in human.10 A mouse homo-
logue has also been identified constituting the seventh member in mouse. Expression of 
Reg genes is increased following injury, supporting a potential role in tissue repair and 
regeneration.12,13 Expression of Reg proteins by colorectal, gastric, and pancreatic adenocar-
cinomas have recently been shown to have an adverse association with patient survival.14-16 
Reg IV was among several genes with increased expression in cancer cell lines selected for 
increased in vitro resistance to the chemotherapeutic agent, 5-FU.6 Reg IV expression was 
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associated with intestinal differentiation in gastric adenocarcinoma17 
and highly elevated in colorectal cancer (CRC).18,19 Reg IV has 
also been identified as a promising marker of hormone refractory 
metastatic prostate cancer.20 Recently we observed the mitogenic 
effect of Reg IV protein, when added to the cultures of human colon 
adenocarcinoma cell lines with subsequent changes in expression 
of genes associated with altered apoptosis and metastasis.21 This 
supports the hypothesis that Reg gene products are responsible for 
altered apoptosis associated with a more aggressive tumor pheno-
type. Here we examined the expression of individual Reg genes in 
human colorectal adenocarcinoma specimens and adenomas from 
multiple intestinal neoplasia (Min) mice heterozygous for a germ-line 
nonsense mutation of the adenomatous polyposis coli (APC) gene. 
These animals spontaneously develop multiple polyps in the small 
and large intestine at 10–12 weeks of age following spontaneous 
second mutation in the APC gene. This study shows specific regional 
expression profiles of Reg genes along the cranio-caudal axis of the 
GI tract. Our results identify aberrant expression of the Reg genes as 
one of the earliest events in gastrointestinal tumorigenesis. Reg IV 
was specifically upregulated at the time of adenoma formation and 
contributed to the increased resistance to apoptotic cell death.
mAteRIALS AnD metHODS
Cell lines and culture. HCT116 and HT29 colon adenocar-
cinoma cells (American Type Culture Collection, Manassas, VA) 
were grown in Dulbecco’s modified Eagle’s medium (Cambrex, 
Walkersville, MD) containing 10% heat inactivated fetal bovine 
serum (Sigma, St. Louis, MO). Cells were placed in serum-free 
media overnight prior to treatment with endotoxin-free recombinant 
human Reg IV (rhR4).22
Human colorectal carcinoma specimens. Five millimeter sections 
and total RNA isolated from human colorectal adenocarcinoma 
specimens and paired normal mucosa were obtained from the Tissue 
Procurement Core of the Siteman Cancer Center, Washington 
University.
Animals. Breeding pairs of C57Bl/6j APCmin/+ mice were obtained 
from Jackson Laboratories (Bar Harbor, ME). Mice were maintained 
on a 10% fat diet (Harlan Teklad, Madison, WI). Young APCmin/+ 
mice were genotyped as previously described.23
Immunohistochemistry. Immunohistochemical staining of 
human colorectal adenocarcinoma specimens and adenoma isolates 
from APCmin/+ mice was performed by using previously characterized 
antibodies against Reg IV22 and Bcl-2 (Transduction laboratory, BD 
Biosciences, Franklin lakes, NJ) in the Digestive Disease Research 
Center Histopathology Core.
Real time RT‑PCR analysis. Total RNA isolated from human 
colorectal adenocarcinoma isolates and paired normal mucosa, 
adenomas from APCmin/+ and their wild-type littermates (APC+/+) 
and human colon adenocarcinoma cells (HCT116 and HT29) was 
converted to cDNA using Superscript II reverse transcriptase and 
random hexanucleotide primers (Invitrogen, Carlsbad, CA). Samples 
were analyzed by real time RT-PCR using Jumpstart Taq DNA 
polymerase (Sigma, St. Louis, MO) and SYBR Green nucleic acid 
stain (Molecular Probes, Eugene, Oregon) or Taqman probes (IDT, 
Coralville, IA) for individual genes. Crossing threshold values for 
individual genes were normalized to GAPDH (murine) or b-Actin 
gene expression. Probe and primer sets used for real time RT-PCR 
analysis are shown in Table 1.
Western blot analysis. Cell lysates from HCT116 and HT29 
cells were subjected to PAGE electrophoresis and blotted on 
to ImmobilinTM-PVDF membranes (Millipore, Bedford, MA). 
Table 1	 Probe	and	primer	sets	for	Real	Time	RT-PCR
gene Species*  Primer Probe & dye
GAPDH M GGCAAATTCAACGGCACAGT AGATGGTGATGGGCTTCCC JOE/AGGCCGAGAATGGGAAGCTTGTCAC/  
   BHQ
b Actin H & M ATCATTGCTCCTCCTGAGCG (F) GCTGATCCACATCTGCTGGAA (R) SYBR
Reg I M CATCCTGCTCTCATGCCTGAT (F) GCAGATGGCAGGTCTTCTTCA (R) TET/CCTGTCTCCAAGCCAAGGCCAGG/BHQ
Reg Ia H TGATGTTCCTGTCTCTGAGCCA (F) CCTTCTGGGCAGCTGATCC (R) SYBR
Reg Ib H TCTGAGCCAAGGCCAGGA (F) GCCTTCTGGGCAGCTGATT (R) SYBR
Reg II M ACAGCCAAGGCCAGGTAGCT (F) GGGCAGTTGATTTTGGCAGA (R) FAM/ACTTCCCCTTGGCTGAAAAAGACCTTCC/ 
   BHQ
Reg III H GTAACAGCTACTCATACGTCTGGA TTG (F) CTCCCAACCTTCTCCATTGG (R) SYBR
Reg IIIa M GGATTGGGCTCCATGATCC (F) TCAGCACATCGGAGTTACTCCA (R) FAM/CCTCCATTGGGRTGTTGACCCATTGT/  
   BHQ
Reg IIIb M TGCCTTGTTTCAGATACCACAGA (F) GGTGTCCTCCAGGCCTCTTT (R) TET/TGGTTTGATGCAGAACTGGCCTGC/BHQ
Reg IIId M GTGTTGCCTGATGTCCCTTTC (F) CAGCTGATGCGTGGAGAAGAC (R) FAM/TTTCTGGGATTGTTCACCTTGTACCCA/  
   BHQ
Reg IIIg M GGTAACAGTGGCCAATATGTA TGG (F) CCACCTCTGTTGGGTTCATAG (R) TET/TGGGCTCCATGACCCGACACTG/BHQ
Reg IV M CGTGCGGCTACTCTTACTGCT (F) AGCTGGGTCTCAAGATATCGCT (R) FAM/CTGGGTAGCTGGCCCCGAAGTCC/  
   BHQ
Reg IV H TGAGCTGCCTGGCCAAA (F) AAGTAACCATAGCAATTGGACTT GTG (R) SYBR
Bcl 2 M TGGATCCAGGATAACGGAAG (F) CAAACAGAGGTCGCATGCTG(R) SYBR
Bcl 2 H CGGTCTCCTGGTGCCATTAT (F) GAAACGTCACCTGCCCCC (R) SYBR
Bcl xL H CCCATGCTCCGTTATCCTG (F) TAAGTCGCCATCCAAGCTGC (R) SYBR
*H, human; M, murine.
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Antibodies were purchased from Transduction laboratory (BD 
Biosciences, Franklin Lakes, NJ) and Santa Cruz Biotechnology (Santa 
Cruz, CA). Specific proteins were detected by enhanced chemilumi-
nescence (ECL) (Amersham Pharmacia Biotech, Piscataway, NJ).
In vitro radiation‑survival colony assay. HCT116 and HT29 
cells were plated at 104 cells/25 cm2 flasks and incubated in serum 
containing media overnight to allow cell adherence. Cultures were 
then incubated in serum free media with or without 100 nM rhR4. 
After 18 hours, cells were subjected to either 0 or 4 Gy g-irradiation 
(IR) in a Gamacel 40 cesium irradiator at 0.96 cGy/min. Cells were 
allowed to grow until the development of microscopically visible 
colonies.
Statistical Analysis. Values were expressed as the mean ± s.e.m. 
Data were analyzed by 2-tailed t test. A p‑value of less than 0.05 was 
considered as statistically significant.
ReSuLtS
Reg IV is most upregulated gene of Reg family in human 
colorectal adenocarcinomas. In order to determine Reg gene expres-
sion in gastrointestinal tumors, we measured the expression of human 
Reg genes in 14 colorectal adenocarcinoma resection specimens and 
paired normal mucosa. mRNA expression of individual Reg genes 
was determined by real time RT-PCR and normalized to b-Actin 
expression. Absolute mRNA level of individual Reg gene was deter-
mined based on titrated standard curve using specific primer sets and 
probes. Reg IV was the dominant member of the Reg gene family 
expressed in normal mucosa (mRNA expression: 6.1 ± 4.5, 0.45 
± 0.2, 0.05 ± 0.03, and 27.2 ± 9.3 of Reg Ia, Reg Ib, Reg III and 
Reg IV respectively) (Fig. 1A). While colorectal adenocarcinoma 
specimens exhibited increased expression of all Reg genes, Reg IV, 
and to a lesser extent Reg Ia constituted the dominant members of 
the Reg gene family expressed by colorectal adenocarcinomas (mRNA 
expression: 492 ± 304, 56 ± 33, 8 ± 6, and 1456 ± 676 of Reg Ia, Reg 
Ib, Reg III and Reg IV respectively) (Fig. 1A). Individual resected 
tumors showed highly unique patterns of Reg gene expression. For 
example, specimen 3 had increased Reg IV expression only, however, 
specimen 2 had increases in expression of all members of the Reg gene 
family including Reg IV. 100%, 86%, 86%, and 71% of colorectal 
adenocarcinoma specimens demonstrated increased Reg IV, III, Ia, 
and Ib expression respectively, greater than 1.5-fold relative to adja-
cent normal mucosa (Fig. 1B). No clear correlation between levels of 
Reg gene expression and a particular histopathology or tumor stage 
was observed (data not shown). Consistent with increased Reg IV 
mRNA, colorectal adenocarcinomas showed prominent expression of 
Reg IV protein by immunohistochemistry (Fig. 1C).
Expression of  Reg  genes is dysregulated early in  tumorigenesis. 
We first characterized the expression of the Reg gene family in the 
normal murine GI tract. Total RNA was isolated from individual 
segments of the GI tract, extending from the stomach to the colon of 
14-week old mice. Reg gene expression was then determined by using 
Taqman probe and primer sets specific for each of the 7 Reg genes 
in the murine genome. Individual Reg genes displayed one of three 
embryologically-derived expression patterns across the cranio-caudal 
axis of the adult GI tract (Fig. 2A). Reg I, II and IIId had maximal 
expression in the foregut-derived stomach and duodenum; Reg IIIa, 
IIIb, and IIIg in midgut-derived small bowel extending from the 
jejunum to the ileum, whereas Reg IV was unique with prominent 
expression in the cecum and colon. We next utilized APCmin/+ mice 
to determine at what step expression of individual Reg genes becomes 
dysregulated during tumorigenesis. We analyzed regional expression 
of different Reg genes in the intestines of four-week old APCmin/+ 
mice and wild-type (APC+/+) littermate controls. four-week old 
wild-type APC+/+ mice had regional expression patterns mirroring 
that shown in 14-week normal adults (data not shown). Compared 
to wild-type APC+/+ mice, different intestinal segments of four-week 
old APCmin/+ mice showed significant increases in expression of all 
Reg genes, except Reg IV (Fig. 2B). Intestinal regions associated 
with the greatest predisposition for adenomatous polyp formation 
had increases of greater than two-fold in Reg I, II, IIIb and IIIg 
expression. Furthermore, segmental increases were seen in both Reg 
members expressed normally at that site (e.g., Reg IIIb in the ileum) 
Figure 1. Reg IV is the dominant member of Reg gene family upregulated 
in human colorectal adenocarcinomas. (A) Absolute mRNA expression of 
Reg Ia, Reg Ib, Reg III and Reg IV genes was determined in 14 surgically resected 
human colorectal adenocarcinomas specimens and paired normal mucosa. 
Expression level of Individual Reg gene was normalized to 1000 arbitrary 
units of b‑actin gene expression and plotted on logarithmic scale. Expression 
profile shows that Reg IV is the dominant member of Reg family expressed at 
higher level in normal mucosa and further increased in colorectal adenocarci‑
nomas. (B) Relative to normal mucosa, fold change in expression of Reg genes 
was determined for individual colorectal adenocarcinoma specimens. 100%, 
86%, 86% and 71% of colorectal adenocarcinoma specimens demonstrated 
increased Reg IV, III, Ia and Ib expression respectively greater than 1.5‑fold. 
(C) Immunohistochemical staining of adenocarcinoma isolates demonstrated 
increased expression of Reg IV protein. Representative sections demonstrate 
strong expression of Reg IV by a subset of cells with goblet‑like morphology 
(left panel) in normal mucosa and staining by all cells (middle and right 
panels) in adenocarcinomas.
www.landesbioscience.com Cancer Biology & Therapy 1717
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as well as Reg genes not expressed at that location (e.g., Reg II and 
IIIg). Further, to determine changes in Reg gene expression associated 
with adenoma development, visible adenomas and adjacent normal 
mucosa were microdissected from 14-week APCmin/+ mice. Cox-2 
expression was used as a marker for successful adenoma isolation. 
Reg IV represented the most commonly increased member of the 
family in 19 individual adenomas when compared to their adjacent 
normal mucosa (≥1.5 fold in 72% of adenomas) (Fig. 3). Similar 
expression profiles of individual Reg genes were also observed in each 
adenoma examined, mirroring human colorectal adenocarcinoma 
specimens.
Reg IV regulates anti‑apoptotic genes. Increased Bcl-2 and Bcl-xL 
expression is a frequent occurrence in colon adenocarcinomas and is 
predictive of poor prognosis.24 To show an upregulation of Bcl-2 in 
APCmin/+ mice, we examined Bcl-2 expression in adenomas by immu-
nohistochemistry (Fig. 4A). In 14-week old wild-type APC+/+ mice 
(WT), staining was largely confined to the lamina propria immune 
cell populations (left panel). Epithelial staining in macroscopically 
normal appearing mucosa from APCmin/+ mice (mAde) was restricted 
to microadenomas (middle panel). However, the epithelium in 
microdissected gross adenomas from APCmin/+ mice (Ade) was glob-
ally stained for Bcl-2 (right panel). Bcl-2 mRNA expression was 
also increased in adenomas and closely paralleled changes in Bcl-2 
protein staining (Fig. 4B). The pronounced increase in Bcl-2 mRNA 
occurred coincides with the development of macroscopic adenomas. 
In addition, adenomas from 14-week APCmin/+ mice with increased 
Reg IV expression generally demonstrated an associated increase in 
Bcl-2 mRNA (Fig. 4C). To establish a causative association between 
Reg IV and anti-apoptotic genes, 100 nM rhR4 was added to cultures 
of human colon adenocarcinoma cell lines (Fig. 5). Bcl-2 and Bcl-xL 
mRNA expression in HCT116 (left panel) and HT29 (right panel) 
cells were determined by real time RT-PCR analysis. Bcl-2 expression 
Figure 2. Reg gene expression varies regionally in the normal murine GI tract 
and is dysregulated in 4‑week old APCmin/+ mice. (A) Taqman probe and 
primer sets specific to individual murine Reg genes were used to determine 
antero‑posterior expression of Reg gene family in the GI tract of normal mice. 
Total RNA isolated from the stomach (ST), duodenum (DU), proximal jejunum 
(PJ), distal jejunum (DJ), ileum (IL), cecum (CE), proximal colon (PC) and distal 
colon (DC) were used for reverse transcriptase reactions (n = 5). Expression 
of Reg genes is plotted as relative expression (%) in the gastrointestinal tract 
by considering highest level as 100. Expression profiles fall into three region‑
ally distinct patterns: foregut (left panel); Reg I, Reg II and Reg IIId, midgut 
(right panel); Reg IIIa, Reg IIIb, and Reg IIIg, or hindgut (left panel); Reg IV. 
(B) 4‑week old APCmin/+ mice and wild‑type APC+/+ littermates were used to 
precisely determine when Reg gene expression becomes dysregulated in a 
model of GI tumorigenesis. Total RNA isolated from the adenoma from DJ, IL, 
CE, and PC segments of four‑week old APCmin/+ mice and wild‑type APC+/+ 
littermate was used for reverse transcriptase reactions (n = 6). At four weeks 
of age, increases in Reg gene expression in APCmin/+ mice precede the 
second spontaneous mutation in the APC gene and histopathologic adenoma 
formation.
Figure 3. Reg IV is the most frequently upregulated member of Reg gene 
family in microdissected adenomas from 14‑week old APCmin/+ mice. 
Adenoma development occurs following a spontaneous mutation in the sec‑
ond copy of the APC gene. The expression of individual murine Reg genes 
were determined using RNA isolated from microdissected adenomas and 
adjacent normal mucosa (n = 19). Cox‑2 mRNA was also measured as a 
marker for effective adenoma isolation. Eighteen of the nineteen adenoma 
samples demonstrated increased Cox‑2 mRNA as expected. Fold increase 
for individual Reg genes compared to adjacent normal mucosa are indi‑
cated. Similar to human colorectal adenocarcinomas, individual adenoma 
demonstrated increased expression of at least one member of the Reg gene 
family. Reg IV represented the most commonly increased member of the 
family (≥1.5 fold in 72% of adenomas).
Reg Gene Expression in Tumorigenesis
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was increased significantly following rhR4-treatment for 2 h in 
HCT116 and 1 h in HT29 cells (Fig. 5A). In addition, significant 
increases in Bcl-xL expression were observed, when rhR4 was added 
to the culture medium of HCT116 cells for 2 h and HT29 cells for 
3 h (Fig. 5A). To determine if the increases in Bcl-2 and Bcl-xL 
mRNA were associated with changes in protein expression, western 
blotting was performed on cell lysates isolated following rhR4 
treatment. Corresponding increases in Bcl-2 and Bcl-xL protein 
were observed in HCT116 and HT29 cells (Fig. 5B). In response to 
rhR4-treatments, increases in Bcl-2 expression occurred earlier than 
that of Bcl-xL. These data show that exogenous Reg IV regulates 
expression of Bcl-2 and Bcl-xL genes and supported our previous 
finding of increased expression of anti-apoptotic genes in response 
to elevated level of Reg IV protein in colorectal adenocarcinoma 
cells.21
Reg IV treatment induces cell survival against radiation‑ 
induced apoptosis. Repressors of programmed cell death may 
directly increase resistance to therapy-induced cell death. We there-
fore investigated a possible protective role of Reg IV in human colon 
adenocarcinoma cells using an in vitro radiation-survival colony 
assay (Fig. 6). HCT116 and HT29 cells grown on culture plates 
containing media with or without 100nM of rhR4 were exposed 
to 4 Gy IR. The microscopically visible colonies in this model are 
reflective of a single surviving and proliferating cell. Exogenous 
Reg IV treatment significantly increased the number of colonies. 
Following 4 Gy IR, colony counts increased from 34.8 ± 5.1 to 
50.4 ± 3.5 (45% increase, p < 0.05) in HCT116 (left panel) and 
Figure 4. Bcl‑2 expression is increased in microdissected adenomas from 14‑week APCmin/+ mice. (A) Representative sections demonstrate normal ileum from 
14‑week old wild‑type APC+/+ mice (normal) showing prominent Bcl‑2 staining (arrowheads) in lamina propria immune cell populations but not in epithelial 
cells (left panel), ileac microadenoma from 14‑week APCmin/+ mice (microadenoma) showing strong Bcl‑2 staining of the adenoma (arrowheads) but in the 
normal surrounding epithelium (middle panel), and ileac gross adenomas from 14‑week APCmin/+ mice (adenoma) showing global staining of epithelium 
cells (right panel). (B) Relative to normal mucosa from wild‑type APC+/+ mice (WT), Bcl‑2 mRNA expression is increased in histologically normal mucosa 
(mAde) and adenomas (Ade) from 14‑week APCmin/+ mice (n = 5). A pronounced increase in Bcl‑2 mRNA occurs coincident with the development of frank 
adenomas. (C) Relative to histologically normal mucosa, fold increases in Reg IV and Bcl‑2 expression in adenomas from 14‑week APCmin/+ mice were used 
to determine correlation between these two genes. Adenomas from APCmin/+ mice with increased Reg IV expression demonstrated an associated increase 
in Bcl‑2 mRNA (Correlation coefficient, R2 = 0.716).
Figure 5. Reg IV treatments increase anti‑apoptotic genes, Bcl‑2 and Bcl‑xL 
in human colon adenocarcinoma cells. (A) HCT116 and HT29 human colon 
adenocarcinoma cell monolayer were treated for various times (h) with 100 
nM rhR4. SYBR green nucleic acid dye and specific primer sets were used to 
determine mRNA expression of Bcl‑2 and Bcl‑xL. Addition of rhR4 to HCT116 
cells (left panel) and HT29 cells (right panel) significantly increased Bcl‑2 and 
Bcl‑xL gene expression (*p < 0.05). B) Western blot showing Bcl‑2 and Bcl‑xL 
protein expression at various times (h) following addition of 100 nM rhR4 to 
HCT116 (left panel) and HT29 cells (right panel). Lower panel indicates the 
intensity of bands by densitometry scanning. Treatments of rhR4 to HCT116 
and HT29 cells led to increased expression of Bcl‑2 and Bcl‑xL proteins and 
demonstrated parallel changes to their respective mRNA expression.
www.landesbioscience.com Cancer Biology & Therapy 1719
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36.8 ± 3.5 to 60.3 ± 5.7 (64% increase, p<0.005) in HT29 cells 
(right panel). In the absence of IR, rhR4 treatment did not result in a 
difference in the number of colonies. This data indicates that Reg IV 
promotes tumor cell survival following a potent apoptotic stimulus.
DISCuSSIOn
Most adenocarcinomas are relatively resistant to CT and IR.25-27 
Efforts to overcome this resistance by increasing concentration of 
cytotoxic drugs or dosage of irradiation has been failed to signifi-
cantly improve the therapeutic response. Apoptosis is a prominent 
mechanism for death of cancer cells following CT or IR.4,26 Novel 
cancer treatment strategies targeting the genes that promote apop-
tosis or blocking factors that inhibit apoptosis may prove adjuvant in 
the treatment of many malignancies. The expression of the Reg gene 
family is increased in common malignancies including colorectal, 
gastric, hepatocellular and pancreatic adenocarcinomas and may have 
an adverse association with patient outcomes or survival.14-17,28 We 
observed increased expression of all genes of Reg family in a series of 
human colorectal adenocarcinoma specimens. Reg IV was the most 
upregulated member of the family in these specimens. This was in 
accordance with previously reported data showing elevated expres-
sion of Reg IV in colorectal carcinomas.18,19
The multistep tumorigenesis model proposed by Vogelstein and 
Fearon describes step-wise transformation from the benign polyp to 
the malignant phenotype of colorectal cancer.1,2 A similar multistep 
process was also observed in a hepatocarcinogenesis model in rats.29 
In each of these models, it appears that tumorigenesis is associated 
with an increased cell proliferation and an associated decrease in 
apoptotic cell death. It is likely that a variety of cellular pathways may 
contribute to decreased apoptosis at specific stages of tumorigenesis. 
This may also be required for the development of a malignant pheno-
type. The APCmin/+ mouse model was chosen, because it mimics 
the developmental process of human GI tumorigenesis. These mice 
spontaneously develop multiple adenomas in small and large intes-
tine at around 10–12 weeks of age following a second spontaneous 
mutation in the APC gene. Compared to wild-type littermate controls 
(APC+/+), four-week old APCmin/+ mice already had significant 
increases in expression of Reg genes, preceding the second spontaneous 
mutation in the APC gene. However, increased Reg IV expression 
was not detected prior to the polyp formation or adenomatous 
changes by histology. Significant increases in Reg IV expression 
were noted in a series of adenomas microdissected from 14-week 
old APCmin/+ mice. This data is first of its kind to demonstrate that 
the Reg IV might have a potential role during adenoma formation 
following second spontaneous mutation in APC gene. These data also 
demonstrated that adenoma formation was associated with increased 
expression of at least one Reg gene, mirroring the results observed 
in human colorectal adenocarcinomas. Our results in the APCmin/+ 
mouse model are in agreement with findings of a 2–3 fold increase 
in Reg IV expression in flat colonic mucosa containing microscopic 
adenomatous changes in three patients with familial adenomatous 
polyposis (data not shown).
Increases in Reg IV expression in adenomas of 14-week old 
APCmin/+ mice had an associated increase in Bcl-2 expression. 
Human colorectal adenocarcinoma specimens with increased Reg IV 
expression exhibited increased expression of Bcl-2 and Bcl-xL mRNA 
(data not shown). A causative role for Reg IV in regulation of the 
Bcl-2 family genes has been confirmed with increased expression of 
Bcl-2 and Bcl-xL at mRNA and prtotein levels following addition of 
rhR4 to culture media of human colon adenocarcinoma cell lines. 
This result supported our previous finding of increased expression 
of anti-apoptotic genes via Reg IV-mediated EGFR/Akt signaling 
cascades.21 Furthermore, addition of rhR4 to human colon adeno-
carcinoma cells led to significantly greater resistance to cell death 
following IR. Functional blocking of Reg IV protein increased cell 
susceptibility to IR-induced death (data not shown). Collectively, 
these data suggest that up-regulation of Reg IV and corresponding 
changes in cellular predisposition to apoptosis may play a requisite 
early role in adenoma formation.
In summary, individual Reg genes show a specific expression 
profile along the canio-caudal axis of the GI tract. The expression of 
Reg genes is increased in colorectal adenocarcinoma and constitutes 
an early event in intestinal tumorigenesis in APCmin/+ mice. While 
the APCmin/+ mouse model does not completely recapitulate human 
colon cancer given the expression of polyps in both the small bowel 
and colon, the model offers the unique opportunity to study genetic 
changes occurring at a premalignant stage, before more profound 
genetic derangements and clonal selection pressures. Increased 
Reg IV expression might lead to a tumor phenotype displaying 
increased resistance to apoptotic cell death. These results identify 
Reg proteins as previously unappreciated regulators of anti-apoptotic 
proteins in early tumorigenesis and may contribute to increased 
resistance to apoptotic death during therapy. Strategies designed to 
reduce endogenous Reg expression or block downstream signaling 
warrant further investigation for use in the prevention or treatment 
of established gastrointestinal adenocarcinomas.
Figure 6. In vitro radiation‑survival colony assay showing decreases in 
radiation‑induced apoptosis following rhR4 treatment in human colon 
adenocarcinoma cells. HCT116 (left panel) and HT29 cells (right panel) 
were plated at 104cells/25 cm2 flask and incubated overnight to allow cell 
adherence. Cultures were then treated with complete media with or without 
100 nM rhR4. After 18 hours cells were subjected to either 0 or 4 Gy IR and 
allowed to grow until the development of visible colonies. Colonies counted 
reflects survival and proliferation of individual cells (lower panel). Addition 
of rhR4 to HCT116 and HT29 cells significantly increased the number of 
surviving cells following 4 Gy IR (A and C, p < 0.05, control vs. 4 Gy IR; B 
and D, p < 0.05, 4 Gy IR vs. 4 Gy IR + rhR4 with HCT116 and HT29 cells 
respectively).
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